Risk factor
Negligible price volatility
Profitability factor
Undervalued vs peers
About
Nipro Corporation, together with its subsidiaries, engages in the medical devices, pharmaceuticals, and pharma packaging businesses. The company's Medical Device business develops, manufactures, and sells various disposable medical products comprising renal, intervention and anesthesiology, injection and infusion, dialysis, cardiopulmonary, diabetic, and cell cultures products; and sells artificial organ-related products, and generic and kit products. Its...
Company Valuation
Considering past and projected metrics, the stock is 'cheaper' than its peers. In particular, the stock is reasonably priced on P/E, of fair value on EV/EBITD.
Target Price
The average target price of 8086.T is 1466 and suggests 5% downside potential. Usually, this means a SELL recommendation among investment firms, or a recommendation to de
Buy
Sell